Nucleic acid test to diagnose cryptosporidiosis

Lab assessment in animal and patient specimens

Zachary Austin Crannell, Alejandro Castellanos, Ayesha Irani, Brittany Rohrman, A. Clinton White, Rebecca Richards-Kortum

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Diarrheal diseases cause more morbidity and mortality around the world than human immunodeficiency virus (HIV), malaria, or tuberculosis. Given that effective treatment of persistent diarrheal illness requires knowledge of the causative organism, diagnostic tests are of paramount importance. The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be responsible for a significant portion of diarrhea morbidity. We present a novel nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samples. The assay uses the isothermal amplification technique recombinase polymerase amplification (RPA) to amplify trace amounts of pathogen DNA extracted from stool to detectable levels in 30 min; products are then detected visually on simple lateral flow strips. The RPA-based Cryptosporidium assay (RPAC assay) was developed and optimized using DNA from human stool samples spiked with pathogen. It was then tested using DNA extracted from the stool of infected mice where it correctly identified the presence or absence of 27 out of 28 stool samples. It was finally tested using DNA extracted from the stool of infected patients where it correctly identified the presence or absence of 21 out of 21 stool samples. The assay was integrated into a foldable, paper and plastic device that enables DNA amplification with only the use of pipets, pipet tips, and a heater. The performance of the integrated assay is comparable to or better than polymerase chain reaction (PCR), without requiring the use of thermal cycling equipment. This platform can easily be adapted to detect DNA from multiple pathogens.

Original languageEnglish (US)
Pages (from-to)2565-2571
Number of pages7
JournalAnalytical Chemistry
Volume86
Issue number5
DOIs
StatePublished - Mar 4 2014

Fingerprint

Nucleic Acids
Animals
DNA
Amplification
Assays
Pathogens
Recombinases
Polymerase chain reaction
Thermal cycling
Viruses
Plastics

ASJC Scopus subject areas

  • Analytical Chemistry

Cite this

Nucleic acid test to diagnose cryptosporidiosis : Lab assessment in animal and patient specimens. / Crannell, Zachary Austin; Castellanos, Alejandro; Irani, Ayesha; Rohrman, Brittany; White, A. Clinton; Richards-Kortum, Rebecca.

In: Analytical Chemistry, Vol. 86, No. 5, 04.03.2014, p. 2565-2571.

Research output: Contribution to journalArticle

Crannell, Zachary Austin ; Castellanos, Alejandro ; Irani, Ayesha ; Rohrman, Brittany ; White, A. Clinton ; Richards-Kortum, Rebecca. / Nucleic acid test to diagnose cryptosporidiosis : Lab assessment in animal and patient specimens. In: Analytical Chemistry. 2014 ; Vol. 86, No. 5. pp. 2565-2571.
@article{dc9dd8744ebd425596ebddac761bcb79,
title = "Nucleic acid test to diagnose cryptosporidiosis: Lab assessment in animal and patient specimens",
abstract = "Diarrheal diseases cause more morbidity and mortality around the world than human immunodeficiency virus (HIV), malaria, or tuberculosis. Given that effective treatment of persistent diarrheal illness requires knowledge of the causative organism, diagnostic tests are of paramount importance. The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be responsible for a significant portion of diarrhea morbidity. We present a novel nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samples. The assay uses the isothermal amplification technique recombinase polymerase amplification (RPA) to amplify trace amounts of pathogen DNA extracted from stool to detectable levels in 30 min; products are then detected visually on simple lateral flow strips. The RPA-based Cryptosporidium assay (RPAC assay) was developed and optimized using DNA from human stool samples spiked with pathogen. It was then tested using DNA extracted from the stool of infected mice where it correctly identified the presence or absence of 27 out of 28 stool samples. It was finally tested using DNA extracted from the stool of infected patients where it correctly identified the presence or absence of 21 out of 21 stool samples. The assay was integrated into a foldable, paper and plastic device that enables DNA amplification with only the use of pipets, pipet tips, and a heater. The performance of the integrated assay is comparable to or better than polymerase chain reaction (PCR), without requiring the use of thermal cycling equipment. This platform can easily be adapted to detect DNA from multiple pathogens.",
author = "Crannell, {Zachary Austin} and Alejandro Castellanos and Ayesha Irani and Brittany Rohrman and White, {A. Clinton} and Rebecca Richards-Kortum",
year = "2014",
month = "3",
day = "4",
doi = "10.1021/ac403750z",
language = "English (US)",
volume = "86",
pages = "2565--2571",
journal = "Analytical Chemistry",
issn = "0003-2700",
publisher = "American Chemical Society",
number = "5",

}

TY - JOUR

T1 - Nucleic acid test to diagnose cryptosporidiosis

T2 - Lab assessment in animal and patient specimens

AU - Crannell, Zachary Austin

AU - Castellanos, Alejandro

AU - Irani, Ayesha

AU - Rohrman, Brittany

AU - White, A. Clinton

AU - Richards-Kortum, Rebecca

PY - 2014/3/4

Y1 - 2014/3/4

N2 - Diarrheal diseases cause more morbidity and mortality around the world than human immunodeficiency virus (HIV), malaria, or tuberculosis. Given that effective treatment of persistent diarrheal illness requires knowledge of the causative organism, diagnostic tests are of paramount importance. The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be responsible for a significant portion of diarrhea morbidity. We present a novel nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samples. The assay uses the isothermal amplification technique recombinase polymerase amplification (RPA) to amplify trace amounts of pathogen DNA extracted from stool to detectable levels in 30 min; products are then detected visually on simple lateral flow strips. The RPA-based Cryptosporidium assay (RPAC assay) was developed and optimized using DNA from human stool samples spiked with pathogen. It was then tested using DNA extracted from the stool of infected mice where it correctly identified the presence or absence of 27 out of 28 stool samples. It was finally tested using DNA extracted from the stool of infected patients where it correctly identified the presence or absence of 21 out of 21 stool samples. The assay was integrated into a foldable, paper and plastic device that enables DNA amplification with only the use of pipets, pipet tips, and a heater. The performance of the integrated assay is comparable to or better than polymerase chain reaction (PCR), without requiring the use of thermal cycling equipment. This platform can easily be adapted to detect DNA from multiple pathogens.

AB - Diarrheal diseases cause more morbidity and mortality around the world than human immunodeficiency virus (HIV), malaria, or tuberculosis. Given that effective treatment of persistent diarrheal illness requires knowledge of the causative organism, diagnostic tests are of paramount importance. The protozoan parasites of the genus Cryptosporidium are increasingly recognized to be responsible for a significant portion of diarrhea morbidity. We present a novel nucleic acid test to detect the presence of Cryptosporidium species in DNA extracted from stool samples. The assay uses the isothermal amplification technique recombinase polymerase amplification (RPA) to amplify trace amounts of pathogen DNA extracted from stool to detectable levels in 30 min; products are then detected visually on simple lateral flow strips. The RPA-based Cryptosporidium assay (RPAC assay) was developed and optimized using DNA from human stool samples spiked with pathogen. It was then tested using DNA extracted from the stool of infected mice where it correctly identified the presence or absence of 27 out of 28 stool samples. It was finally tested using DNA extracted from the stool of infected patients where it correctly identified the presence or absence of 21 out of 21 stool samples. The assay was integrated into a foldable, paper and plastic device that enables DNA amplification with only the use of pipets, pipet tips, and a heater. The performance of the integrated assay is comparable to or better than polymerase chain reaction (PCR), without requiring the use of thermal cycling equipment. This platform can easily be adapted to detect DNA from multiple pathogens.

UR - http://www.scopus.com/inward/record.url?scp=84900651318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900651318&partnerID=8YFLogxK

U2 - 10.1021/ac403750z

DO - 10.1021/ac403750z

M3 - Article

VL - 86

SP - 2565

EP - 2571

JO - Analytical Chemistry

JF - Analytical Chemistry

SN - 0003-2700

IS - 5

ER -